A new artificial intelligence algorithm can accurately assess the risk of cancer associated with indeterminate pulmonary nodules in patients' lungs, according to a study published in American Journal of Respiratory and Critical Care Medicine.
Oncology
Thomas Jefferson University will no longer purchase the Fox Chase Cancer Center from Temple University due to the "devastating economic impact of COVID-19."
The amount of Americans undergoing routine cancer screenings has plummeted during the pandemic, according to Epic data cited by STAT.
The costs of dozens of cancer drugs were about 2.3 times higher in the U.S. than in Europe even though they had similar clinical benefits, according to a study cited by STAT.
Researchers at Danville, Pa.-based Geisinger have successfully used a blood test to diagnose presymptomatic cancer patients for the first time, according to a study published in Science.
Grisel Fernandez-Bravo, DNP, CEO of Memorial Hospital Miramar (Fla.), has had to find new ways to manage operations after treatment for her cancer diagnosis left her immunocompromised and susceptible to COVID-19.
New research shows that cancer patients who contract COVID-19 are nearly three times more likely to die that COVID-19 patients who do not have cancer, a new study shows.
Memphis, Tenn.-based St. Jude Children's Research Hospital partnered with the International Society of Paediatric Oncology to launch a global COVID-19 data registry and resource center for pediatric cancer.
AstraZeneca will start a clinical trial to see if its cancer drug Calquence can suppress the excessive immune response COVID-19 triggers in some patients, the drugmaker said April 14.